Aminocaproic acid - SOLOpharm

Indications for use
-
Bleeding (hyperfibrinolysis, hypo- and afibrinogenemia);
-
Bleeding during surgical interventions and pathological conditions, accompanied by an increase in fibrinolytic activity of the blood (during neurosurgical, intracavitary, thoracic, gynecological and urological surgeries, including on the prostate gland, lungs, pancreas; tonsillectomy, after dental procedures, during bypass surgeries, during surgeries on the ear, throat, nose vessels);
-
Visceral diseases with hemorrhagic syndrome;
-
Premature separation of placenta, prolonged retention of the dead fetus in utero, complicated abortion
-
prevention of secondary hypofibrinogenemia during massive transfusions of preserved blood.
Therapeutic class:
Haemostatic agent - Fibrinolysis inhibitor
INN
Aminocaproic acid